JP2005218602A - Production method of tube containing contrast medium - Google Patents

Production method of tube containing contrast medium Download PDF

Info

Publication number
JP2005218602A
JP2005218602A JP2004028932A JP2004028932A JP2005218602A JP 2005218602 A JP2005218602 A JP 2005218602A JP 2004028932 A JP2004028932 A JP 2004028932A JP 2004028932 A JP2004028932 A JP 2004028932A JP 2005218602 A JP2005218602 A JP 2005218602A
Authority
JP
Japan
Prior art keywords
tube
contrast medium
contrast agent
ray contrast
powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004028932A
Other languages
Japanese (ja)
Inventor
Kenji Nishino
憲司 西野
Masahide Takahashi
正英 高橋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nichias Corp
Original Assignee
Nichias Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nichias Corp filed Critical Nichias Corp
Priority to JP2004028932A priority Critical patent/JP2005218602A/en
Publication of JP2005218602A publication Critical patent/JP2005218602A/en
Pending legal-status Critical Current

Links

Abstract

<P>PROBLEM TO BE SOLVED: To provide a high-quality tube containing a contrast medium excellent in surface nature and durability thereof with higher yields by inhibiting the coagulation of an X-ray contrast medium, and further, a whitening inorganic filler. <P>SOLUTION: In the production method of the tube containing the contrast medium having the X-ray contrast medium contained within the tube wall, the powder of the X-ray contrast medium granulated below 20 μm in particle size and dried is added to a hot melting fluorine resin and after melted and mixed at a temperature above the melting temperature of the hot melting fluorine resin, it is pelletized to make pellets. Then, the pellets thus obtained are molded into a tube. <P>COPYRIGHT: (C)2005,JPO&NCIPI

Description

本発明は、X線造影剤を管壁内に含有する造影剤入りチューブの製造方法に関する。   The present invention relates to a method for manufacturing a tube containing a contrast medium containing an X-ray contrast medium in a tube wall.

例えば、輸血や輸液を行う際に血管内部との連通を保持するための留置カテーテルや、診断や治療のためのカテーテル等に、硫酸バリウムや酸化ビスマス等のX線造影剤を高分子材料からなる管壁内に混入した造影剤入りチューブが従来から使用されている(例えば、特許文献1参照)。   For example, X-ray contrast agents such as barium sulfate and bismuth oxide are made of a polymer material for an indwelling catheter for maintaining communication with the inside of a blood vessel when blood transfusion or infusion is performed, or a catheter for diagnosis or treatment. Conventionally, a contrast agent-containing tube mixed in the tube wall has been used (see, for example, Patent Document 1).

しかし、X線造影剤は粉末であるため、凝集しやすく、図1のSEM断面写真で示されるように、凝集物Aとなって造影剤入りチューブの管壁中に存在して亀裂や破損の起点になったり、表面に凹凸を形成することがあり、信頼性や品質、歩留まりを低下させる大きな原因になっている。   However, since the X-ray contrast medium is a powder, it easily aggregates, and as shown in the SEM cross-sectional photograph of FIG. It may become a starting point or unevenness may be formed on the surface, which is a major cause of reducing reliability, quality, and yield.

また、X線造影剤として広く用いられている酸化ビスマスはかなり明確な黄色の粉末であり、そのまま高分子材料に混入して成形すると、造影剤入りチューブも明確な黄色を呈するようになる。医療用の部材では白色であることが好感される場合があり、そのため造影剤入りチューブでは、酸化チタン等の白色化無機充填剤を配合して白色化する等の対応がとられている。しかし、白色化無機充填剤は粉末であることから、X線造影剤と同様に凝集物となって造影剤入りチューブの管壁中に存在することがある。   In addition, bismuth oxide widely used as an X-ray contrast agent is a fairly clear yellow powder, and when mixed with a polymer material as it is and molded, the tube containing the contrast agent also exhibits a clear yellow color. In some cases, a medical member is favorably white. Therefore, a tube containing a contrast medium is whitened by adding a whitening inorganic filler such as titanium oxide. However, since the whitening inorganic filler is a powder, it may be present in the tube wall of the contrast agent-containing tube as an aggregate in the same manner as the X-ray contrast agent.

特開平5−154192号公報JP-A-5-154192

本発明はこのような状況に鑑みてなされたものであり、X線造影剤、更には白色化無機充填剤の凝集を抑え、耐久性に優れ、表面性状に優れた高品質の造影剤入りチューブを歩留まり良く製造することを目的とする。   The present invention has been made in view of such a situation. A tube containing a high-quality contrast agent that suppresses aggregation of an X-ray contrast agent and further a whitening inorganic filler, has excellent durability, and has excellent surface properties. It aims at manufacturing with good yield.

上記目的を達成するために、本発明は、X線造影剤を管壁内に含有する造影剤入りチューブの製造方法であって、熱溶融性フッ素樹脂に、粒径20μm以下に分級し乾燥したX線造影剤粉末を添加し、前記熱溶融性フッ素樹脂の溶融温度以上の温度にて溶融混合した後、ペレタイズ化してペレットを作製し、次いで得られたペレットをチューブ状に成形することを特徴とする造影剤入りチューブの製造方法を提供する。   In order to achieve the above object, the present invention is a method for producing a tube containing a contrast agent containing an X-ray contrast agent in the tube wall, wherein the tube is classified into a heat-melting fluororesin to a particle size of 20 μm or less and dried. X-ray contrast agent powder is added, melt-mixed at a temperature equal to or higher than the melting temperature of the heat-meltable fluororesin, pelletized to produce pellets, and then the resulting pellets are formed into a tube shape A method for producing a tube containing a contrast medium is provided.

本発明によれば、成形材料の調製に際し、X線造影剤粉末や白色化無機充填剤の分散性が高まり、得られる造影剤入りチューブもこれらの凝集物が管壁中に存在せず、亀裂や破損の発生が抑えられ、表面に凹凸が形成されることもなく、歩留まりも高まる。   According to the present invention, in the preparation of the molding material, the dispersibility of the X-ray contrast agent powder and the whitening inorganic filler is increased, and the resulting contrast agent-containing tube does not have these aggregates in the tube wall and cracks. And the occurrence of breakage is suppressed, the surface is not uneven, and the yield is increased.

以下、本発明に関して詳細に説明する。   Hereinafter, the present invention will be described in detail.

本発明において、造影剤入りチューブの高分子材料として熱溶融性フッ素樹脂を用いるが、中でも四フッ化エチレン−エチレン共重合体、四フッ化エチレン−六フッ化プロピレン共重合体及び四フッ化エチレン−パーフルオロアルコキシエチレン共重合体が好ましい。これらは単独でも、適宜組み合わせて用いてもよい。   In the present invention, a heat-meltable fluororesin is used as a polymer material for a tube containing a contrast agent. Among them, a tetrafluoroethylene-ethylene copolymer, a tetrafluoroethylene-hexafluoropropylene copolymer, and a tetrafluoroethylene are used. -Perfluoroalkoxyethylene copolymers are preferred. These may be used alone or in appropriate combination.

上記の熱溶融性フッ素樹脂には、20μm以下に分級され、かつ乾燥されたX線造影剤粉末が添加される。分級・乾燥したX線造影剤粉末を用いることにより、結晶水・吸着水が除去され、粒径が均一となるため、熱溶融性フッ素樹脂との混合前に凝集することが無くなり、結果として熱溶融性フッ素樹脂への分散性が高まり、最終的に造影剤入りチューブとしたときも凝集物になり難くなる。X線造影剤の種類には制限がなく、酸化ビスマス、オキシ塩化ビスマス、次炭酸ビスマス、硝酸ビスマス、タングステン酸ビスマス、硫酸バリウム等の公知のものを用いることができる。尚、粒径の下限は特に制限は無いが、微細になりすぎると凝集が起こりやすくなるため、0.2μm以上が好ましい。   X-ray contrast agent powder classified to 20 μm or less and dried is added to the above hot-melt fluororesin. By using the classified and dried X-ray contrast agent powder, water of crystallization and adsorbed water are removed and the particle size becomes uniform, so there is no agglomeration before mixing with the hot-melt fluoropolymer, resulting in heat The dispersibility in the meltable fluororesin is increased, and it becomes difficult to form an aggregate even when a tube containing a contrast medium is finally formed. There is no restriction | limiting in the kind of X-ray contrast agent, Well-known things, such as bismuth oxide, bismuth oxychloride, bismuth subcarbonate, bismuth nitrate, bismuth tungstate, barium sulfate, can be used. The lower limit of the particle size is not particularly limited, but is preferably 0.2 μm or more because aggregation tends to occur when the particle size becomes too fine.

分級は、篩を用いる等して容易に実施することができる。また、乾燥は、X線造影剤粉末を110〜130℃の加熱炉に入れ、10〜15時間維持すればよい。   Classification can be easily performed using a sieve or the like. The drying may be performed by placing the X-ray contrast medium powder in a heating furnace at 110 to 130 ° C. and maintaining for 10 to 15 hours.

X線造影剤粉末の添加量は、実用的な造影作用が得られる量であれば制限されるものではないが、造影剤入りチューブ用成形材料全量の5〜25質量%が適当である。特に添加量が25質量%を超えると、X線造影剤粉末の凝集物が生成しやすくなり、更には相対的に熱溶融性フッ素樹脂の量が減るため、成形性に劣るようになり、得られる造影剤入りチューブも可撓性に劣るようになる。   The amount of X-ray contrast agent powder added is not limited as long as a practical contrast effect can be obtained, but 5 to 25% by mass of the total amount of the contrast agent-containing tube molding material is appropriate. In particular, when the addition amount exceeds 25% by mass, aggregates of X-ray contrast agent powder are likely to be formed, and furthermore, since the amount of the heat-meltable fluororesin is relatively reduced, the moldability becomes inferior. The contrast-contained tube obtained is also less flexible.

また、X線造影剤粉末として酸化ビスマスを使用した場合、白色化のために白色化無機充填剤粉末を造影剤入りチューブ用成形材料全量の1〜3質量%添加することが好ましい。白色化無機充填剤の種類には制限はなく、酸化チタン等の公知のものを用いることができる。但し、白色化無機充填剤として、分散性をより高めるために、酸化アルミニウムで被覆した酸化チタンを用いることがより好ましい。被覆方法は、例えば、硫酸アルミニウム水溶液に酸化チタンを投入して攪拌により分散させ、水酸化アルミニウムで中和して取り出し、熱処理すればよい。   Further, when bismuth oxide is used as the X-ray contrast agent powder, it is preferable to add 1 to 3% by mass of the whitened inorganic filler powder for the whitening of the total amount of the contrast agent-containing tube molding material. There is no restriction | limiting in the kind of whitening inorganic filler, Well-known things, such as a titanium oxide, can be used. However, it is more preferable to use titanium oxide coated with aluminum oxide as a whitening inorganic filler in order to further improve dispersibility. As the coating method, for example, titanium oxide may be added to an aluminum sulfate aqueous solution, dispersed by stirring, neutralized with aluminum hydroxide, taken out, and heat-treated.

この白色化無機充填剤も、凝集を抑えるために、乾燥しておくことが好ましい。乾燥方法はX線造影剤粉末と同様である。   This whitening inorganic filler is also preferably dried in order to suppress aggregation. The drying method is the same as that for the X-ray contrast medium powder.

また、本発明では、X線造影剤粉末及び白色化無機充填剤粉末の分散性を更に高めるために、ジオルガノポリシロキサン化合物を添加する。ジオルガノポリシロキサン化合物は、シロキサンポリマーの硅素原子の夫々に2個の有機基を有する化合物であり、例えば、特殊メチルフェニルシロキサン(YF−33、東芝シリコン製)、ジメチルシロキサン(KF−96、信越シリコン製)、ポリジメチルシロキサン(バイフルイドM、バイエル製)、メチルフェニルシロキサン(KF−54、信越シリコン製)等を市場から入手して使用できる。   Moreover, in this invention, in order to further improve the dispersibility of X-ray contrast agent powder and whitening inorganic filler powder, a diorganopolysiloxane compound is added. The diorganopolysiloxane compound is a compound having two organic groups on each silicon atom of the siloxane polymer, such as special methylphenylsiloxane (YF-33, manufactured by Toshiba Silicon), dimethylsiloxane (KF-96, Shin-Etsu). Silicon), polydimethylsiloxane (Bifluid M, Bayer), methylphenylsiloxane (KF-54, Shin-Etsu Silicon), etc. can be obtained from the market and used.

ジオルガノポリシロキサンの添加量は、造影剤入りチューブ用成形材料全量の0.01〜0.3質量%とすることが好ましい。添加量が0.01質量%未満では分散性を向上させる効果が得られず、0.3質量%を超えて添加しても更なる分散性の向上が認められず、不経済となる。   The addition amount of the diorganopolysiloxane is preferably 0.01 to 0.3% by mass with respect to the total amount of the contrast agent-containing tube molding material. If the addition amount is less than 0.01% by mass, the effect of improving the dispersibility cannot be obtained, and even if the addition amount exceeds 0.3% by mass, no further improvement in dispersibility is observed, which is uneconomical.

造影剤入りチューブを製造するには、先ず、熱溶融性フッ素樹脂に、X線造影剤粉末と、必要に応じて、ジオルガノポリシロキサン化合物と、白色化無機充填剤粉末とを添加し、熱溶融性フッ素樹脂の溶融温度以上の温度にて溶融混合する。それぞれの原料を溶融混合する前に予め、ヘンシェルミキサー、V型ミキサー、ダブルコーン型ミキサー等の混合機を用いて混合することもできる。溶融混合は、例えば二軸押出成形機等を用いて行うことができる。   In order to manufacture a tube containing a contrast agent, first, an X-ray contrast agent powder and, if necessary, a diorganopolysiloxane compound and a whitening inorganic filler powder are added to a heat-meltable fluororesin, Melt and mix at a temperature higher than the melting temperature of the meltable fluororesin. Each raw material can be mixed in advance using a mixer such as a Henschel mixer, a V-type mixer, or a double cone mixer before being melt-mixed. The melt mixing can be performed using, for example, a twin screw extruder.

次いで、例えばストランド状に押出成形してペレットを作製する。   Next, for example, a pellet is produced by extrusion molding into a strand shape.

そして、得られたペレットを押出成形機に供給して所定形状のチューブ状に押出成形することにより造影剤入りチューブが得られる。得られる造影剤入りチューブは、X線造影剤粉末や白色化無機充填剤粉末に由来する凝集物がなく、耐久性に優れ、表面性状に優れたものとなる。   The obtained pellets are supplied to an extrusion molding machine and extruded into a tube having a predetermined shape to obtain a contrast medium-containing tube. The obtained contrast agent-containing tube is free from aggregates derived from the X-ray contrast agent powder and the whitened inorganic filler powder, and has excellent durability and surface properties.

以下に実施例及び比較例を挙げて本発明を更に説明するが、本発明はこれに限定されるものではない。   Hereinafter, the present invention will be further described with reference to examples and comparative examples, but the present invention is not limited thereto.

(実施例1〜3及び比較例1)
熱溶融性フッ素樹脂として四フッ化エチレン−エチレン共重合樹脂(旭硝子製「アフロンCOP C88AX」;表1にETFEと標記)または四フッ化エチレン−パーフルオロアルコキシエチレン共重合樹脂(三井デュポンフロロケミカル製「440HP−J」;表1にPFAと標記)を用意した。また、X線造影剤粉末として酸化ビスマス粉末(日本化学産業製「FP」)を20μm以下に分級して110℃で12時間乾燥したもの、並びに硫酸バリウム粉末(堺化学製「B−1」)を20μm以下に分級して110℃で12時間乾燥したものを用意した。また、白色化無機充填剤として酸化チタン(堺化学製「A−171」)を用意した。また、比較のために、上記酸化ビスマスを分級せず、乾燥しないものを用意した。
(Examples 1 to 3 and Comparative Example 1)
Tetrafluoroethylene-ethylene copolymer resin ("Aflon COP C88AX" manufactured by Asahi Glass; labeled ETFE in Table 1) or tetrafluoroethylene-perfluoroalkoxyethylene copolymer resin (manufactured by Mitsui Dupont Fluorochemical) “440HP-J”; indicated as PFA in Table 1) was prepared. Further, bismuth oxide powder (“FP” manufactured by Nippon Kagaku Sangyo Co., Ltd.) as X-ray contrast agent powder is classified to 20 μm or less and dried at 110 ° C. for 12 hours, and barium sulfate powder (“B-1” manufactured by Sakai Chemical). Was prepared to be 20 μm or less and dried at 110 ° C. for 12 hours. In addition, titanium oxide (“A-171” manufactured by Sakai Chemical) was prepared as a whitening inorganic filler. For comparison, a bismuth oxide that was not classified and did not dry was prepared.

そして、上記の各材料を表1に示す割合にて二軸押出成形機(シリンダー径15mm)に投入し、更にそれぞれにシリコンオイル(信越化学工業製「KF−96」)を0.2質量%となるように添加した後、ETFEを用いた場合には280℃、PFAを用いた場合は370℃にてそれぞれ溶融混合した。次いで、シリンダー・押出ヘッドを285℃に設定した二軸押出成形機にて各混合物をストランド状に押出成形してペレットを作製した。そして、各ペレットを押出成形機に投入し、外径2mm、内径1mmのチューブ状に成形した。   Each of the above materials was put into a twin-screw extruder (cylinder diameter: 15 mm) at the ratio shown in Table 1, and 0.2% by mass of silicon oil (“KF-96” manufactured by Shin-Etsu Chemical Co., Ltd.) was added to each. Then, the mixture was melt-mixed at 280 ° C. when ETFE was used and 370 ° C. when PFA was used. Next, each mixture was extruded into a strand shape with a twin-screw extruder with a cylinder / extrusion head set at 285 ° C. to produce pellets. Each pellet was put into an extrusion molding machine and formed into a tube shape having an outer diameter of 2 mm and an inner diameter of 1 mm.

得られた各造影剤入りチューブの色調及び外観不良を目視して評価し、更に断面のSEM写真を撮影して凝集物の有無を確認して分散性を評価した。分散性については粒径20μm以上の大径粒子が管壁中に存在する場合を「不良」とし、存在しない場合を「良好」とした。なた、外観不良については表面に凹凸が見られるときを「あり」とし、凹凸が見られないときを「なし」とした。結果を表1に併記する。   The color tone and appearance defect of each obtained contrast agent-containing tube were visually evaluated, and further, a cross-sectional SEM photograph was taken to confirm the presence or absence of aggregates and to evaluate dispersibility. Regarding dispersibility, the case where large particles having a particle diameter of 20 μm or more were present in the tube wall was determined as “poor”, and the case where no particles were present was determined as “good”. As for the appearance defect, when there was unevenness on the surface, “Yes” was indicated, and when there was no unevenness, “No” was indicated. The results are also shown in Table 1.

表1に示すように、本発明に従い、分級・乾燥したX線造影剤粉末を用い、更にシリコンオイルを添加することにより、X線造影剤粉末の分散性が高まり、凝集物の無い造影剤入りチューブが得られることがわかる。   As shown in Table 1, according to the present invention, classified and dried X-ray contrast agent powder is used, and further by adding silicone oil, the dispersibility of the X-ray contrast agent powder is increased, and a contrast agent containing no aggregate is contained. It turns out that a tube is obtained.

従来の造影剤入りチューブにおける不具合を説明するための図であり、断面を撮影したSEM写真である。It is a figure for demonstrating the malfunction in the conventional contrast agent containing tube, and is the SEM photograph which image | photographed the cross section.

Claims (5)

X線造影剤を管壁内に含有する造影剤入りチューブの製造方法であって、熱溶融性フッ素樹脂に、粒径20μm以下に分級し乾燥したX線造影剤粉末を添加し、前記熱溶融性フッ素樹脂の溶融温度以上の温度にて溶融混合した後、ペレタイズ化してペレットを作製し、次いで得られたペレットをチューブ状に成形することを特徴とする造影剤入りチューブの製造方法。   A method for producing a tube containing a contrast medium containing an X-ray contrast medium in a tube wall, wherein the X-ray contrast medium powder classified to a particle size of 20 μm or less and dried is added to a heat-meltable fluororesin, and the heat melting A method for producing a contrast agent-containing tube, which comprises melt-mixing at a temperature equal to or higher than the melting temperature of the conductive fluororesin, pelletizing to produce pellets, and then forming the obtained pellets into a tube shape. 前記熱溶融性フッ素樹脂が、四フッ化エチレン−エチレン共重合体、四フッ化エチレン−六フッ化プロピレン共重合体及び四フッ化エチレン−パーフルオロアルコキシエチレン共重合体から選択されることを特徴とする請求項1記載の造影剤入りチューブの製造方法。   The heat-meltable fluororesin is selected from tetrafluoroethylene-ethylene copolymer, tetrafluoroethylene-hexafluoropropylene copolymer, and tetrafluoroethylene-perfluoroalkoxyethylene copolymer. The method for producing a tube containing a contrast medium according to claim 1. ジオルガノポリシロキサン化合物を添加することを特徴とする請求項1または2記載の造影剤入りチューブの製造方法。   3. The method for producing a contrast agent-containing tube according to claim 1, wherein a diorganopolysiloxane compound is added. 白色化無機充填剤粉末を添加することを特徴とする請求項1〜3の何れか1項に記載の造影剤入りチューブの製造方法。   The whitening inorganic filler powder is added, The manufacturing method of the contrast agent containing tube of any one of Claims 1-3 characterized by the above-mentioned. 前記白色化無機充填剤粉末が、酸化アルミニウムで被覆された酸化チタンであることを特徴とする請求項4記載の造影剤入りチューブの製造方法。   The method for producing a tube containing a contrast agent according to claim 4, wherein the whitened inorganic filler powder is titanium oxide coated with aluminum oxide.
JP2004028932A 2004-02-05 2004-02-05 Production method of tube containing contrast medium Pending JP2005218602A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004028932A JP2005218602A (en) 2004-02-05 2004-02-05 Production method of tube containing contrast medium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004028932A JP2005218602A (en) 2004-02-05 2004-02-05 Production method of tube containing contrast medium

Publications (1)

Publication Number Publication Date
JP2005218602A true JP2005218602A (en) 2005-08-18

Family

ID=34994708

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004028932A Pending JP2005218602A (en) 2004-02-05 2004-02-05 Production method of tube containing contrast medium

Country Status (1)

Country Link
JP (1) JP2005218602A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012130557A (en) * 2010-12-22 2012-07-12 Junkosha Co Ltd Medical tube containing contrast medium
CN103497463A (en) * 2013-10-23 2014-01-08 北京市塑料研究所 FEP guide tube achieving filling modification with barium sulfate
CN115350336A (en) * 2022-08-12 2022-11-18 深圳市骏鼎达新材料股份有限公司 Developing catheter

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012130557A (en) * 2010-12-22 2012-07-12 Junkosha Co Ltd Medical tube containing contrast medium
CN103497463A (en) * 2013-10-23 2014-01-08 北京市塑料研究所 FEP guide tube achieving filling modification with barium sulfate
CN115350336A (en) * 2022-08-12 2022-11-18 深圳市骏鼎达新材料股份有限公司 Developing catheter
CN115350336B (en) * 2022-08-12 2023-12-15 深圳市骏鼎达新材料股份有限公司 Developing catheter

Similar Documents

Publication Publication Date Title
TWI438242B (en) Method for manufacturing polyarylene sulfide resin composition
EP2751199B1 (en) Process for mixing polyvinyl chloride with a bio-based plasticizer
KR20080053518A (en) A polymer composition with uniformly distributed nano-sized inorganic particles
TW200641003A (en) Polymeric composites having enhanced reversible thermal properties and methods of forming thereof
JPH03218806A (en) Thermoplastic interpenetrating network structure body and its forming method
US20100267902A1 (en) Process
JP2006328352A (en) Insulating thermally-conductive resin composition, molded product, and method for producing the same
WO2012161327A1 (en) Cable-coating vinyl chloride resin composition and cable using same
JP2005218602A (en) Production method of tube containing contrast medium
JP6359425B2 (en) Porous aluminum nitride particles
JP2011195710A (en) White resin molded product and led reflector
KR102225150B1 (en) Fluororesin and mesoporous silica composition and molded product thereof
JP7022153B2 (en) Composition and method for producing the composition
JP3075797B2 (en) High dielectric resin composition
JP2003073497A (en) Fluorine-based resin porous body and method for producing the same
CN113698670A (en) Calcium-zinc stabilizer and application thereof in SPC floor base material production
JP2019104678A (en) Scaly glass granule and method for producing the same
TW201639710A (en) Dye ribbon for sublimation thermal transfer printing
CN106243704A (en) A kind of led cooling respirator nylon material and preparation method thereof
JPH05154192A (en) Tube containing contrast medium
JP7343150B2 (en) Molding materials and molded bodies for rotational molding
JP6532204B2 (en) Polyamide resin composition
US20120219743A1 (en) Polymer composition comprising tungsten treated titanium dioxide having improved photostability
WO2019232818A1 (en) Granule for cable having relatively high tensile strength and hardness, and preparation process thereof
JP2707103B2 (en) Pelletized fluororesin composition

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20060327

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060913

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20071129

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20080908

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081001

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081127

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090310